sur Curatis Holding AG (isin : CH1330780979)
Curatis Establishes Expert Advisory Board to Guide Healthcare Innovations
Curatis Holding AG has announced the formation of an Advisory Board composed of four globally recognized experts in medical and scientific fields. This board includes leaders in pediatric oncology, neurology, drug development, and biochemistry, to steer Curatis's research initiatives and strategic plans.
CEO Roland Rutschmann expressed enthusiasm for welcoming these experts, emphasizing the board's importance in accelerating innovation to tackle critical healthcare challenges. Stewart Goldman, Prof. Dr. Andreas Gantenbein, Dr. Anthony Man, and Prof. Dr. Arnim Pause will provide invaluable guidance.
This development marks a pivotal point in Curatis's aim to become a leading provider of specialized medicines in Europe, enhancing healthcare innovation and patient outcomes. This strategic decision underscores Curatis's dedication to advancing medical science.
R. H.
Copyright © 2025 FinanzWire, tous droits de reproduction et de représentation réservés.
Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.
Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève
Voir toutes les actualités de Curatis Holding AG